Pharmaceuticals

Orchid income at Rs 162 crore

By Our Corporate Bureau | 04 Nov 2003

Zydus Cadila Q2 net rises 30%

By Our Corporate Bureau | 20 Oct 2003

Orchid Pharma's API facilities inspected by EDQM, MHRA UK

By Our Corporate Bureau | 06 Oct 2003

Caraco Pharma gets USFDA nod for tizanidine hydrochloride

By He noted that the compan | 03 Oct 2003

Kopran may rope in strategic financial partner for recast plan

By Nisha Das | 24 Sep 2003

Unichem Laboratories to set up formulations facility in Himachal

By Nisha Das | 24 Sep 2003

Ranbaxy to invest Rs 120 crore for R&D in Andhra Pradesh

By Hyderabad: | 22 Sep 2003

Meet brings to fore opportunities in European pharma industry

By Our Corporate Bureau | 22 Sep 2003

Orchid JV manufacturing facility in China commissioned

By Our Corporate Bureau | 20 Sep 2003

Jitendra N Doshi to be interim chief of Caraco Pharmaceuticals

By Doshi joined Caraco from | 30 Aug 2003

Mumbai to host Global Pharma Business Convention soon

By Our Corporate Bureau | 23 Aug 2003

Hikal''s main focus : Pharma

By Mumbai: | 09 Aug 2003

Aurobindo Pharma to invest Rs 50 crore for R&D centre in Mumbai

By Nisha Das | 29 Jul 2003

In the pink of health

By John P. Matthew | 21 Jul 2003

Hikal declares bonus share of 1 : 2

By Mumbai: | 14 Jul 2003

Wockhardt buys CP Pharma

By Our Corporate Bureau | 10 Jul 2003

There is no plan to sell Vitamin B12 business, says Wockhardt

By Our Corporate Bureau | 24 Jun 2003

Pharma MNCs to tap Indian market post-patent regime

By Nisha Das | 09 May 2003

Zydus Cadila's net profit zooms by 27%

By Our | 03 May 2003

Kee Pharma offers Melagenina Plus for vitiligo patients

By Priced at Rs 3,600 per b | 24 Apr 2003

BIFR issues show-cause notice to wind up Sol Pharmaceuticals

By Our Corporate Bureau | 19 Apr 2003

Access to medicines

By D G Shah | 17 Apr 2003

Indian pharma sector on path to prepare for global collaboration

By P K Hari | 24 Mar 2003

Domestic Viagra market to sizzle as Kopran cuts price of Nyte

By Nisha Das | 17 Mar 2003

Shasun launches Shacryl-30 D; gets US company’s licence

By Our Corporate Bureau | 03 Mar 2003